Company Category: Asthma

Strados Labs

Strados Labs is a medical technology company focused on improving the lives of patients with respiratory diseases. Enabling remote monitoring of lung health, Strados Labs’ RESP Biosensor allows clinicians to continuously measure patients’ lung sounds such as cough and wheeze that can indicate an exacerbation or reduced quality of life. The technology is used to assist drug developers in demonstrating treatment efficacy in clinical trials and to support clinicians in disease surveillance and management. The RESP Biosensor is FDA-cleared, CE marked and HIPAA compliant, backed by multiple awards and clinical publications. Strados Labs is privately owned and based in Philadelphia, PA.

Read More

STEMCELL Technologies

STEMCELL Technologies supports cancer research with a comprehensive portfolio of more than 2,500 specialized tools and services. From high-quality cell culture media and simplified cell separation technologies to high-performance instruments, including the STEMprep™ Tissue Dissociator for generating high-viability single-cell suspensions and the CellPore™ Transfection System for gentle intracellular delivery, our solutions help researchers achieve reliable, reproducible results. Complemented by essential accessories and expert scientific services, our products support every step of the cancer research workflow. STEMCELL Technologies is a trusted partner to scientists worldwide advancing discoveries in cancer biology, stem cell research, immuno-oncology, regenerative medicine, and cellular therapy. | STEMCELL Technologies develops specialty cell culture media, iPSCs and iPSC-derived cells, cell isolation products, and accessory reagents for life science research. Whether you are modeling retinal diseases, advancing drug discovery, or studying human retinal development, the STEMdiff™ retinal cell culture system supports every step of your iPSC-retinal workflow. Build robust, functional human retinal pigment epithelial (RPE) models using the STEMdiff™-ACF RPE Differentiation Kit and STEMdiff™-XF RPE Maturation Medium, which are designed to support reproducibility, scalability, and physiological relevance in vitro. Backed by rigorous quality control and over 30 years of in vitro modeling expertise, STEMCELL’s tools help you move confidently from basic research to translational applications. Visit stemcell.com to learn more. | With more than 30 years of in vitro modeling expertise, STEMCELL Technologies supports respiratory researchers with specialized cell culture media and accessory reagents to build physiologically relevant and reproducible pulmonary models at the air-liquid interface (ALI) or as organoids. Model all regions of the human lung using our comprehensive PneumaCult™ portfolio, which enables the expansion and differentiation of primary airway and alveolar epithelial cells. You can generate well-differentiated, pseudostratified epithelia at the ALI or as apical-in and apical-out airway organoids to study airway biology and respiratory diseases, and advance drug development. To model lung development or complex lung disorders, STEMdiff™ cell culture media comes with standardized differentiation protocols to generate lung progenitors and branching lung organoids from human pluripotent stem cells. By combining reliable innovative culture solutions, and expert scientific support, STEMCELL helps you build more predictive models to meet your evolving research or workflow requirements. Learn more at www.stemcell.com.

Read More

Springer Nature

Springer Nature is a leading global scientific, technical and medical portfolio, providing researchers with quality content through innovative products and services from trusted brands like Springer, Nature Portfolio, and BMC. Springer Nature has one of the strongest STM and HSS eBook collections and a comprehensive range of hybrid and open access journals. Visit our booth to learn about the benefits of publishing with us and to browse our latest titles on display. | Springer Nature advances discovery by serving the whole research community. All the research we publish is robust and in the best possible format to be discovered, accessed, used, re-used and shared. Springer Nature is home to brands including [Springer, Nature Research, BMC, Palgrave Macmillan and Scientific American]. Please visit our booth to learn about publishing with us. | Springer Nature is a leading global research, educational and professional publisher, home to an array of trusted brands, including Springer, Nature Portfolio, Palgrave Macmillan, BioMed Central, and Scientific American. We provide quality content for the Genetics community through innovative products and services, extensive eBook collections, and hybrid/open access journals across the sciences and humanities. Meet with our editors to learn about the benefits of publishing with us. Find out more: www.springernature.com | Springer Nature advances discovery by serving the whole research community. All the research we publish is robust and in the best possible format to be discovered, accessed, used, re-used and shared. Springer Nature is home to brands including [Springer, Nature Research, BMC, Palgrave Macmillan and Scientific American]. Please visit springernature.com and @SpringerNature. | Springer Nature is one of the world’s leading global research, educational and professional publishers, home to an array of respected and trusted brands providing quality content through a range of innovative products and services. Springer Nature advances discovery by publishing trusted research, supporting the development of new ideas and championing open science. We are committed to playing our part in accelerating solutions to address the world’s urgent challenges. The newest addition to the Springer Nature family of products is protocols.io, a secure platform for developing, optimizing, sharing, and running reproducible research methods. | Springer Nature Information and insights to drive research, development and excellence Fuel your innovation pipeline and improve commercial outcomes with Springer Nature’s comprehensive portfolio of content and solutions. With over 150 years of expertise in scientific publishing, we are a trusted partner to life sciences organizations, providing the insights, data and platforms needed to accelerate research, enhance decision-making, and drive business success. Our solutions empower biopharma and biotech professionals to stay ahead in a rapidly evolving industry: AdisInsight Make confident decisions in drug development In the fast-paced world of biopharma, every decision counts. AdisInsight provides trusted, expertly curated intelligence on drug development, clinical trials, deals and safety, empowering you to act with certainty. Stay Ahead: Updated daily with the latest drug and trial data. Trust Your Data: Expert-validated insights with full transparency on sources. Seamless Integration: Plug directly into your internal analytics for deeper insights. Strategic Advantage: Identify opportunities, track competitors and accelerate decision-making. Navigate drug development with confidence with AdisInsight. adisinsight.springer.com Biopharma Dealmakers Make biopharma connections today Biopharma Dealmakers is the premier platform connecting life sciences innovators, investors and pharma leaders. Get exclusive deal insights, funding trends and opportunities to showcase your company. Trusted Industry Insights: Editorial coverage on M&A, licensing, and funding. Global Reach: Distributed with Nature Biotechnology and Nature Reviews Drug Discovery. Partnering Opportunities: Feature your company’s assets, innovations and investment needs. Branded Content: Tailored campaigns to position your company in front of the right audience. Connect, partner and accelerate your next deal with Biopharma Dealmakers. nature.com/biopharmdeal protocols.io Accelerate innovation with reproducible research protocols.io is a secure, interactive platform for developing and sharing research methods, ensuring standardization, collaboration, and compliance. Reproducibility First: Step-by-step protocols with version tracking. Seamless Collaboration: Share, comment, and refine methods in real time. Compliance-Ready: Supports HIPAA and 21 CFR Part 11 compliance. Institutional Knowledge: Preserve protocols and expertise within your organization. Streamline research and ensure reproducibility with protocols.io. protocols.io Nature Portfolio Engage the STEM community with impact Reach a global community of scientists, healthcare professionals and decision-makers with Nature Portfolio’s advertising and content solutions. Unmatched Reach: 55M monthly users, 6.5M newsletter subscribers, 100K podcast listeners. Precision Targeting: Data-driven campaigns for maximum engagement. Multi-Channel Advertising: Digital, print, email and podcast options. Branded Content: Award-winning storytelling aligned with Nature’s trusted voice. Align your brand with scientific excellence—partner with Nature Portfolio. partnerships.nature.com Text and Data Mining (TDM) With the ever-expanding volume of valuable information becoming available daily, any fragment of it could hold the key to the next breakthrough. By analysing this information, and uncovering patterns and trends, you can get the insights you need to fast-track innovation. By choosing Springer Nature’s API as your data source, you’ll have access to our extensive collection of high-quality groundbreaking research, across all subject areas. All of our data is from a trusted, peer-reviewed content source, giving you information you can trust and ultimately leading to higher quality output. You can apply our data to meet a limitless range of business goals, from understanding trending topics to finding potential collaborators to building new products. Data Solutions (TDM) | Springer Nature is a leading global scientific, technical and medical publisher, providing researchers with innovative information, products and services. | Springer is a leading global research publisher, providing researchers with quality Radiology content through innovative information, products and services. As part of Springer Nature, Springer sits alongside other trusted brands like Nature Portfolio and BMC to provide a comprehensive range of books, eBook collections, and hybrid/open access journals. Visit our booth to learn about the benefits of publishing with us and to browse our latest titles on display.

Read More

Society for Advanced Bronchoscopy

The Society for Advanced Bronchoscopy (SAB) is an international organization of health care professionals committed to improving health through the study, prevention, diagnosis, and management of advanced bronchoscopy techniques. Our mission is to promote and support excellence in interpretive skills and technical knowledge of those involved in advanced bronchoscopy and to help maintain professional practice integrity.

Read More

SCIREQ – an emka TECHNOLOGIES company

SCIREQ & emka offer in vivo, in vitro and ex vivo research instruments & telemetry hardware for physiology, pharmacology, and toxicology. Our solutions provide unparalleled accuracy and reproducibility for respiratory, cardiovascular, and neurology studies, as cited in over 7,500 scientific publications. Come chat with us at Booth 2100!

Read More

Regeneron and Sanofi

Regeneron and Sanofi collaborate to jointly develop certain fully-human monoclonal antibody therapies under a global collaboration agreement. Regeneron is a leading biotechnology company that that invents life-transforming medicines for serious diseases. Sanofi is a global biopharmaceutical company focused on human health. For more information, visit www.Regeneron.com and www.Sanofi.com.

Read More

PulmOne USA Inc.

Learn more about the MiniBox+: The only complete Pulmonary Function Testing (PFT) system with portable, cabinless plethysmography. FAST: Lung Volumes, Spirometry and DLCO testing in as little as 20 minutes. EASY: Fully automated testing. LVMs with only 1 minute of tidal breathing. PROVEN: High reliability and reproducibility, lung volumes equivalent to body plethysmography. Visit our booth for a demo.

Read More

PAREXEL

Parexel is a leading global clinical development partner providing insights-driven Clinical and Consulting solutions to the world’s life sciences industry. Leveraging deep local knowledge and a global breadth of clinical, regulatory and therapeutic expertise, our 22,000+ global employees work in partnership with biopharmaceutical leaders, emerging innovators and sites to design and deliver clinical trials with patients in mind — broadening access and making clinical research a care option for anyone, anywhere. Our proven track record spans 40+ years and drives us forward, advancing clinical research in healthcare’s most complex areas while harnessing innovation to drive efficiencies across every phase of the clinical development process. Our insights-driven approach, proven delivery and trusted execution are accelerating the delivery of life-changing treatments to patients — With Heart.™ | Parexel is among the world’s largest CROs, providing full range of Phase I to IV clinical development services to help life-saving treatments reach patients faster. Leveraging the breadth of our clinical, regulatory and therapeutic expertise, we collaborate with biopharmaceutical leaders, emerging innovators and sites to design and deliver clinical trials for patients. We work With HeartTM every day to treat patients with dignity and learn from their experiences, so every trial makes a difference.

Read More